{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:39Z","timestamp":1790334819839,"version":"4.1.0"},"reference-count":126,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Psoriasis is a chronic immunologic disease involving inflammation that can target internal organs, the skin, and joints. The peak incidence occurs between the age of 30 and 40 years, which overlaps with the typical reproductive period of women. Because of comorbidities that can accompany psoriasis, including metabolic syndrome, cardiovascular involvement, and major depressive disorders, the condition is a complex one. The role of hormones during pregnancy in the lesion dynamics of psoriasis is unclear, and it is important to resolve the implications of this pathology during pregnancy are. Furthermore, treating pregnant women who have psoriasis represents a challenge as most drugs generally prescribed for this pathology are contraindicated in pregnancy because of teratogenic effects. This review covers the state of the art in psoriasis associated with pregnancy. Careful pregnancy monitoring in moderate-to-severe psoriasis vulgaris is required given the high risk of related complications in pregnancy, including pregnancy-induced hypertensive disorders, low birth weight for gestational age, and gestational diabetes. Topical corticosteroids are safe during pregnancy but effective only for localised forms of psoriasis. Monoclonal antibodies targeting cytokines specifically upregulated in psoriasis, such as ustekinumab (IL-12\/23 inhibitor), secukinumab (IL-17 inhibitor) can be effective for the severe form of psoriasis during pregnancy. A multidisciplinary team must choose optimal treatment, taking into account fetal and maternal risks and benefits.<\/jats:p>","DOI":"10.3390\/medicina57080804","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T21:43:53Z","timestamp":1628199833000},"page":"804","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["State-of-the-Art Review of Pregnancy-Related Psoriasis"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-0199","authenticated-orcid":false,"given":"Anca Angela","family":"Simionescu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Mihaela","family":"Danciu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Neonatology, \u201cDr. Alfred Rusescu\u201d National Institute for Maternal and Child Health, 127715 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-9470","authenticated-orcid":false,"given":"Ana Maria Alexandra","family":"Stanescu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijwd.2019.04.021","article-title":"Clinical considerations for the management of psoriasis in women","volume":"5","author":"Gottlieb","year":"2019","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/120347540200600608","article-title":"Psoriasis and pregnancy","volume":"6","author":"Tauscher","year":"2002","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-3083.2010.03917.x","article-title":"Pregnancy outcomes in women with moderate-to-severe psoriasis","volume":"25","author":"Nachum","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden","volume":"98","author":"Haerskjold","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3899\/jrheum.101124","article-title":"Cardiovascular comorbidities in psoriasis and psoriatic arthritis: Pathogenesis, consequences for patient management, and future research agenda: A report from the GRAPPA 2009 annual meeting","volume":"38","author":"Boehncke","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3899\/jrheum.130797","article-title":"Depression and anxiety in psoriatic disease: Prevalence and associated factors","volume":"41","author":"McDonough","year":"2014","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ad.2013.06.004","article-title":"Psoriasis in pregnancy: A review (I)","volume":"105","author":"Ruiz","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e23068","DOI":"10.1097\/MD.0000000000023068","article-title":"Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0022-202X.2005.23703.x","article-title":"Genetics of psoriasis in Iceland: Evidence for linkage of subphenotypes to distinct Loci","volume":"124","author":"Karason","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.jid.5700118","article-title":"Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients\u2014An analysis of 1019 HLA-C- and HLA-B-typed patients","volume":"126","author":"Gudjonsson","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hailfinger, S., and Schulze-Osthoff, K. (2021). The paracaspase MALT1 in psoriasis. Biol. Chem.","DOI":"10.1515\/hsz-2021-0250"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3389\/fimmu.2018.02239","article-title":"Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease","volume":"9","author":"Israel","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Vural, S., Kerl, K., Do\u011fan, P.E., Vollmer, S., Puchta, U., He, M., Arakawa, Y., Heper, A.O., Karal, A., and Hartmann, D. (2021). Lesional activation of Tc 17 cells in Beh\u00e7et\u2019s disease and psoriasis supports HLA-class I-mediated autoimmune responses. Br. J. Dermatol.","DOI":"10.1111\/bjd.20643"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and postpartum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-4362.2003.01760.x","article-title":"Clinical course of psoriasis during pregnancy","volume":"42","author":"Raychaudhuri","year":"2003","journal-title":"Int. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","article-title":"Psoriatic arthritis disease activity during pregnancy and the first-year postpartum","volume":"46","author":"Polachek","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1684\/ejd.2020.3885","article-title":"Psoriasis and pregnancy","volume":"30","author":"Richard","year":"2020","journal-title":"Eur. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","article-title":"Psoriasis and pregnancy: Hormone and immune system interaction","volume":"35","author":"Boyd","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breastfeeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Simionescu, A.A., Horobe\u021b, A., Bela\u015fcu, L., and Median, D.M. (2020). Real-World Data Analysis of Pregnancy-Associated Breast Cancer at a Tertiary-Level Hospital in Romania. Medicina, 56.","DOI":"10.3390\/medicina56100522"},{"key":"ref_22","first-page":"417","article-title":"Chemotherapy for breast cancer during pregnancy and postpartum: A retrospective descriptive study","volume":"63","author":"Simionescu","year":"2015","journal-title":"Farmacia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jid.2011.271","article-title":"The impact of psoriasis on pregnancy outcomes","volume":"132","author":"Lima","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T Lymphocytes and Allograft Rejection","volume":"7","author":"Marino","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The Inflammatory Response in Psoriasis: A Comprehensive Review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3389\/fimmu.2019.02317","article-title":"Dynamic Function and Composition Changes of Immune Cells during Normal and Pathological Pregnancy at the Maternal-Fetal Interface","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2007.09.014","article-title":"Fetal tolerance in human pregnancy\u2014A crucial balance between acceptance and limitation of trophoblast invasion","volume":"115","year":"2008","journal-title":"Immunol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1095\/biolreprod.107.060632","article-title":"Dendritic Cells: Key to Fetal Tolerance?","volume":"77","author":"Blois","year":"2007","journal-title":"Biol. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12948-016-0048-x","article-title":"How pregnancy can affect autoimmune diseases progression?","volume":"14","author":"Piccinni","year":"2016","journal-title":"Clin. Mol. Allergy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2133.2003.05725.x","article-title":"A nail psoriasis severity index","volume":"150","author":"Baran","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/IJWH.S125784","article-title":"Pustular psoriasis of pregnancy: Current perspectives","volume":"10","author":"Trivedi","year":"2018","journal-title":"Int. J. Womens Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1590\/abd1806-4841.20132134","article-title":"Pustular psoriasis of pregnancy (impetigo herpetiformis)\u2014Case report","volume":"88","author":"Kondo","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1753495X15626623","article-title":"Two case reports of generalized pustular psoriasis of pregnancy: Different outcomes","volume":"9","author":"Flynn","year":"2016","journal-title":"Obstet. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2019-11-6","DOI":"10.7573\/dic.2019-11-6","article-title":"Management of psoriasis in pregnancy-a review of the evidence to date","volume":"9","author":"Ferreira","year":"2020","journal-title":"Drugs Context"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/acr.23747","article-title":"Psoriatic Arthritis Disease Activity During and After Pregnancy: A Prospective Multicenter Study","volume":"71","author":"Ursin","year":"2019","journal-title":"Arthritis Care Res."},{"key":"ref_38","first-page":"257","article-title":"Hormonal influences on women with psoriasis","volume":"61","author":"Mowad","year":"1998","journal-title":"Cutis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1346-8138.1998.tb02357.x","article-title":"Factors influencing psoriasis: An analysis based upon the extent of involvement and clinical type","volume":"25","author":"Park","year":"1998","journal-title":"J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2133.1989.tb01338.x","article-title":"Psoriasis: Improvement during and worsening after pregnancy","volume":"120","author":"Dunna","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3899\/jrheum.091172","article-title":"Informing response criteria for psoriatic arthritis. I: Discrimination models based on data from 3 anti-tumor necrosis factor randomized studies","volume":"37","author":"Gladman","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3899\/jrheum.100479","article-title":"Informing response criteria for psoriatic arthritis (PsA). II: Further considerations and a proposal\u2014The PsA joint activity index","volume":"37","author":"Gladman","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.2010.129379","article-title":"Development of a preliminary composite disease activity index in psoriatic arthritis","volume":"70","author":"Mumtaz","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.1991.tb04952.x","article-title":"Measurement of involved surface area in patients with psoriasis","volume":"124","author":"Ramsay","year":"1991","journal-title":"Br. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2014Oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12329912","article-title":"The self-administered psoriasis area and severity index is valid and reliable","volume":"106","author":"Feldman","year":"1996","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2133.2000.03418.x","article-title":"The salford psoriasis index: An holistic measure of psoriasis severity","volume":"142","author":"Kirby","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/ard.2010.129726","article-title":"Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?","volume":"69","author":"Eder","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jid.2017.05.023","article-title":"Melanocytes: Target Cells of an HLA-C*06:02-Restricted Autoimmune Response in Psoriasis","volume":"137","author":"Prinz","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Pahar, B., Madonna, S., Das, A., Albanesi, C., and Girolomoni, G. (2020). Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections. Vaccines, 8.","DOI":"10.3390\/vaccines8030517"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Beaumont, P.E., McHugh, B., Findlay, E.G., Mackellar, A., Mackenzie, K.J., Gallo, R.L., Govan, J.R., Simpson, A.J., and Davidson, D.J. (2014). Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099029"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.2010-2395","article-title":"A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum","volume":"96","author":"Jung","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1753495X19847832","article-title":"Glucocorticoids in pregnancy","volume":"13","author":"Pofi","year":"2020","journal-title":"Obstet. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3389\/fphys.2018.01091","article-title":"The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation","volume":"9","author":"Napso","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_59","first-page":"196","article-title":"Activation of Blood CD3+CD56+CD8+ T Cells during Pregnancy and Multiple Sclerosis","volume":"8","author":"Alonso","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_60","first-page":"1","article-title":"Estrogen receptor \u03b1 in T cells suppresses follicular helper T cell responses and prevents autoimmunity","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/PTT.S82975","article-title":"Psoriasis in pregnancy: Challenges and solutions","volume":"5","author":"Vena","year":"2015","journal-title":"Psoriasis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1083-3188(03)00040-8","article-title":"Impetigo herpetiformis unresponsive to therapy in a pregnant adolescent","volume":"16","author":"Arslanpence","year":"2003","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"300060520933811","DOI":"10.1177\/0300060520933811","article-title":"A case of impetigo herpetiformis in which termination of pregnancy was required","volume":"48","author":"Yao","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2010.02.005","article-title":"Psoriasis and pregnancy outcomes: A nationwide population-based study","volume":"64","author":"Yang","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jaad.2009.05.004","article-title":"Pregnancy outcomes in psoriasis: Why do we know so little?","volume":"61","author":"Horn","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/jp.2010.53","article-title":"Increased cord serum inflammatory markers in small-for-gestational-age neonates","volume":"31","author":"Amarilyo","year":"2011","journal-title":"J. Perinatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/14767058.2010.511340","article-title":"Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth","volume":"24","author":"Bastek","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0030-1249366","article-title":"Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes","volume":"27","author":"Sorokin","year":"2010","journal-title":"Am. J. Perinatol."},{"key":"ref_69","first-page":"126","article-title":"Pregnancy outcomes in inflammatory skin diseases","volume":"52","author":"Onan","year":"2018","journal-title":"Turk. Arch. Dermatol. Venerol. Turkderm"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000265557","article-title":"Smoking and alcohol intake in severely affected patients with psoriasis in Germany","volume":"220","author":"Gerdes","year":"2010","journal-title":"Dermatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: A systematic review of observational studies","volume":"175","author":"Bobotsis","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_72","first-page":"10546","article-title":"Incidence of peri-pregnancy flares among psoriasis patients","volume":"81","author":"Lee","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3899\/jrheum.171218","article-title":"The effect of pregnancy on disease activity in patients with psoriatic arthritis","volume":"45","author":"Berman","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/jid.2014.35","article-title":"No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis","volume":"134","author":"Harder","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejogrb.2021.01.043","article-title":"Pustular psoriasis of pregnancy managed with labor induction","volume":"259","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/1744666X.2015.1037742","article-title":"Psoriasis during pregnancy: Characteristics and important management recommendations","volume":"11","author":"Hoffman","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2008.03.018","article-title":"Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases","volume":"59","author":"Lam","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40257-015-0137-5","article-title":"Treating Psoriasis during Pregnancy: Safety and Efficacy of Treatments","volume":"16","author":"Bangsgaard","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: Serial monitoring in breastfed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bcp.12122","article-title":"Tacrolimus placental transfer at delivery and neonatal exposure through breast milk","volume":"76","author":"Zheng","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","article-title":"Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus","volume":"70","author":"Kainz","year":"2000","journal-title":"Transplantation"},{"key":"ref_83","first-page":"905","article-title":"Safety of tacrolimus in pregnancy","volume":"60","author":"Nevers","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"ref_84","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","volume":"26","author":"Chi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.jaad.2013.09.009","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation","volume":"70","author":"Butler","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_86","first-page":"E59","article-title":"Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review","volume":"13","author":"Han","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","article-title":"Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis","volume":"26","author":"Rabie","year":"2011","journal-title":"Lasers Med. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archdermatol.2011.1614","article-title":"Narrowband UV-B phototherapy during pregnancy and folic acid depletion","volume":"148","author":"Park","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaad.2009.10.006","article-title":"Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo","volume":"62","author":"Koo","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archderm.1991.01680030067008","article-title":"Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (P.U.V.A.) for the treatment of psoriasis","volume":"127","author":"Stern","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.25251\/skin.2.supp.90","article-title":"A Comprehensive Survey Assessing the Family Planning Needs of Women with Psoriasis","volume":"2","author":"Lebwohl","year":"2018","journal-title":"SKIN J. Cutan. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Saf."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.02.062","article-title":"The use of cyclosporine in dermatology: Part II","volume":"63","author":"Ryan","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007890-199502270-00005","article-title":"Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients","volume":"59","author":"Armenti","year":"1995","journal-title":"Transplantation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamadermatol.2013.5768","article-title":"Pregnancy outcomes after maternal exposure to topical corticosteroids: A UK population-based cohort study","volume":"149","author":"Chi","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2003-40605","article-title":"Antenatal steroid use is associated with increased gastroesophageal reflux in neonates","volume":"20","author":"Chin","year":"2003","journal-title":"Am. J. Perinatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa071453","article-title":"Long-term outcomes after repeat doses of antenatal corticosteroids","volume":"357","author":"Wapner","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","article-title":"Pregnancy outcome after first trimester exposure to corticosteroids: A prospective controlled study","volume":"18","author":"Gur","year":"2004","journal-title":"Reprod. Toxicol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Mazzotta","year":"2000","journal-title":"Teratology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2019.05.066","article-title":"Fetal methotrexate syndrome: A systematic review of case reports","volume":"87","author":"Verberne","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/tera.1420520407","article-title":"Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy","volume":"52","author":"Sturkenboom","year":"1995","journal-title":"Teratology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/bdra.20078","article-title":"Acitretin embryopathy: A case report","volume":"70","author":"Barbero","year":"2004","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"ref_103","unstructured":"(2021, August 02). Retinoids Containing Medicinal Products-A31-1446; Acitretin; Adapalene; Alitretinoin; Bexarotene; Isotretinoin; Tretinoin; Tazarotene. European Medicines Agency Retinoids Containing Medicinal Products-A31-1446; Acitretin; Adapalene; Alitretinoin; Bexarotene; Isotretinoin; Tretinoin; Tazarotene. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/retinoid-article-31-referral-prac-assessment-report_en.pdf."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5801280","DOI":"10.1155\/2018\/5801280","article-title":"Impetigo Herpetiformis: Review of Pathogenesis, Complication, and Treatment","volume":"2018","author":"Namazi","year":"2018","journal-title":"Dermatol. Res. Pract."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Johansen, C.B., Jimenez-Solem, E., Haerskjold, A., Sand, F.L., and Thomsen, S.F. (2018). The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051349"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/BOR.0b013e328344a732","article-title":"Treatment with biologics of pregnant patients with rheumatic diseases","volume":"23","author":"Ostensen","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: Fatal case of disseminated B.C.G. infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J. Crohns Colitis"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000262284","article-title":"Treatment of psoriasis with anti-TNF drugs during pregnancy: Case report and review of the literature","volume":"220","author":"Puig","year":"2010","journal-title":"Dermatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: Results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_112","unstructured":"(2021, July 16). European Medicines Agency Certolizumab Pegol (Cimzia) Summary of Product Characteristics. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cimzia-epar-product-information_en.pdf."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdrb.20250","article-title":"Development in the cynomolgus macaque following administration of Ustekinumab, a human anti-IL-12\/23p40 monoclonal antibody, during pregnancy and lactation","volume":"89","author":"Martin","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1016\/S0016-5085(18)32145-0","article-title":"Su1799\u2013Pregnancy outcomes in women exposed to Ustekinumab","volume":"154","author":"Mahadevan","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_115","unstructured":"(2021, May 30). STELARA\u00ae Ustekinumab R U.S. Food and Drug Administration, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761044lbl.pdf."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-020-01346-4","article-title":"Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) during Pregnancy: A Review","volume":"80","author":"Gisbert","year":"2020","journal-title":"Drugs"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjd.17086","article-title":"Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: A case series of 10 pregnancies","volume":"180","author":"Watson","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The E.U.L.A.R. points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bjd.16901","article-title":"Secukinumab in pregnancy: Outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database","volume":"179","author":"Warren","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update","volume":"183","author":"Smith","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"And 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_123","unstructured":"(2021, July 16). European Medicines Agency Etanercept (Enbrel) Summary of Product Characteristics [Internet] 2019. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enbrel-epar-product-information_en.pdf."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbspin.2008.04.016","article-title":"Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature","volume":"76","author":"Berthelot","year":"2009","journal-title":"Jt. Bone Spine"},{"key":"ref_125","first-page":"1014","article-title":"Tumor necrosis factor-alpha inhibition and V.A.T.E.R. association: A causal relationship","volume":"33","author":"Carter","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/bdra.23033","article-title":"Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy","volume":"94","author":"Chambers","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/804\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:41:13Z","timestamp":1760164873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":126,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["medicina57080804"],"URL":"https:\/\/doi.org\/10.3390\/medicina57080804","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]}}}